T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT - Test2 - elhamkhani - TriplyDB

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

http://www.wikidata.org/entity/Q34398411

about

Haploidentical Stem Cell Transplantation in Adult Haematological Malignancies How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published Literature HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide Modern approaches to HLA-haploidentical blood or marrow transplantation Alternative Donor Transplantation for Acute Myeloid Leukemia Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.Overview of the progress on haploidentical hematopoietic transplantation.A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.Antithymocyte globulin in allogeneic hematopoietic cell transplantation: benefits and limitations.Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.Lower incidence of acute GVHD is associated with the rapid recovery of CD4+CD25+CD45RA+ regulatory T cells in patients who received haploidentical allografts from NIMA-mismatched donors: A retrospective (development) and prospective (validation) coh Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update.Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EB Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.Similar incidence of severe acute GVHD and less severe chronic GVHD in PBSCT from unmanipulated, haploidentical donors compared with that from matched sibling donors for patients with haematological malignancies.Comparison of outcomes in hematological malignancies treated with haploidentical or HLA-identical sibling hematopoietic stem cell transplantation following myeloablative conditioning: A meta-analysis.Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission.Tumorablative conditioning regimen for haploidentical stem cell transplantation in 102 children with hematologic malignancies: a single-center experience.Haploidentical hematopoietic SCT using helical tomotherapy for total-body irradiation and targeted dose boost in patients with high-risk/refractory acute lymphoblastic leukemia.Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia.Advances in haploidentical stem cell transplantation for hematologic malignancies.The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.Efficacy and Safety of Unmanipulated Haploidentical Related Donor Allogeneic Peripheral Blood Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia.Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients.

P2860

Q26745527-01BC2259-5F87-4440-8141-C90E89C083C6 Q26748867-F7612DD7-2A58-495E-9E14-A4A34D4C5863 Q26749454-A95A37EF-4EE1-48B0-B0A9-72FB2B4AFB3C Q26752908-7B18F32F-E0F9-481C-812F-6FFF9CA9A763 Q26797506-F3DD95A1-ED53-4990-9255-EC5C1CD05EB5 Q26799456-37963485-6531-411E-8361-57960ACE47EB Q28080943-6E965855-FD61-43FB-A211-81B0ADFCB084 Q33746730-D7B737C6-4EF4-4232-B06D-124AD7298589 Q35834570-FD73CEBB-6239-4D0F-AE89-B68EC8E3604B Q35888941-0B993017-5F5E-4CD7-893E-096B095D8237 Q36151241-5022EE3E-D4A0-4F29-8E3E-F76F60F2CA0B Q36794295-0AE16A9D-EDB8-4083-B60D-330D0160614E Q36822659-FA6217D2-5919-4E85-A945-962F28C9C83E Q37148409-B17B3EBE-D69F-424F-882A-DB848830A5DF Q37522577-373600AE-76F9-4311-B14E-07491EA9063D Q37595693-0EB40DE4-1368-462F-89A1-216BC16206F3 Q37681792-0E69A099-AB00-48F1-85D6-731711AF3567 Q38773356-633D8C20-B358-4603-828D-279EBF1CD485 Q38839140-C0427874-FA0B-45FA-AFF2-E854903A05F7 Q38879062-87209074-687F-4BCA-AD0B-50223E623C70 Q38970849-D378D6B7-2895-40EC-A255-9D55D5CB08ED Q39670316-D82FB516-773A-4D43-9CE4-C802FD57D5D5 Q42391573-971376AA-9EC7-4C88-AF96-1475402EBE2E Q45795174-BA6AA056-004D-4A9C-B6B3-017455239693 Q47635659-2C989084-CD86-4F7F-8068-2053D4A3C714 Q47648662-B2896584-06F9-4411-8D85-57E644CB0047 Q48141387-A4BD8A8B-F180-4A94-9A38-EE95B4690D6C Q48359012-B3693186-27EB-4FCB-88CD-906848B80D1F Q49575803-5F65053D-0A5C-4210-8D27-EBC3E1DF0FBB Q50058678-627EAB98-F172-4A19-B213-F0403EF52268 Q50580277-DA089478-5BC9-4FEE-BD13-6848F5DDBBFF Q51636737-4C40AB9E-BA17-4A3C-BA1F-6CF1CA5970AF Q52678836-E7CA6A18-CDCF-4DF5-B6D2-705713B17617 Q53091032-E20A53ED-7897-4F62-A591-88ABCE194BE5 Q55263365-E2735657-9425-4B8C-9389-53EE6C4F9DAE Q55398415-4791A993-916B-4561-94F5-035BDBE35FB4

P2860

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

http://www.wikidata.org/entity/Q34398411

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@ast

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@en

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@nl

type

label

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@ast

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@en

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@nl

prefLabel

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@ast

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@en

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@nl

P1433

Q34398411-84D62083-45D4-45F0-AB0F-87CDC879656E

P1476

Q34398411-E8A0FE9D-6724-4D94-9CF9-5D3E8421DB77

P2093

Q34398411-0FFB025F-0B16-48B2-AC36-5893DAA851C4

Q34398411-1097D28D-979D-4FF7-9D8B-CF59DA2001A8

Q34398411-132002F5-920F-4A5F-932C-2F86E833D65C

Q34398411-14B70105-818C-49FC-9D73-081446807418

Q34398411-43FC155B-4119-4911-8F2C-3968B33E2473

Q34398411-53EDD29B-C829-40F7-AA65-3DE549733C48

Q34398411-8D1BE57D-8784-4D12-BE33-D243BBB6E049

Q34398411-903C9703-884C-4AA5-815E-4CD8CB34614D

Q34398411-AAC3E951-56CA-433B-AD9B-A94D4E245ACF

Q34398411-B1D698FF-9679-455E-818F-36F9EE448360

P2860

Q34398411-0B132D94-3F2F-487F-935B-47666A146916

Q34398411-1096D353-7B63-4742-B8DC-1AB8EC771466

Q34398411-1B23967D-B626-4009-A88D-D235296C0681

Q34398411-2529E3E2-1A75-447D-A84F-C1C1598B1450

Q34398411-2F4FD397-8AC4-4813-9FC6-56982EE3EC92

Q34398411-3046E04B-AB1C-4DA9-A6FD-19B2A0939BE3

Q34398411-40079E5F-C451-402E-8A22-2E91D09E1E7F

Q34398411-40CD1E13-C67B-4B18-81F0-00286E977BE3

Q34398411-5D81986D-8AEF-42E8-B29A-04F06EFAAF33

Q34398411-6019C603-6258-4A42-907C-39A7B3D77E1C

P304

Q34398411-51B6F6BC-45CF-4D4F-9B79-408EDE480E94

P31

Q34398411-E5CDFE3D-A2EB-433F-8F74-E607C43DA29D

P356

Q34398411-B78957F3-AECB-41D2-A5A9-B13144F11732

P407

Q34398411-F731F9C9-3F9B-4DC5-BEF2-8DD204EA240F

P433

Q34398411-130E677B-1007-476D-9E37-A232D43DFA93

P478

Q34398411-38FBBF48-61FC-4DA2-8E55-A0E8E2C931A0

P50

Q34398411-A187A98B-C441-4217-859B-AFED0DB8B8F8

P577

Q34398411-B251C2DA-D4A0-417D-A21F-E6DDB28D0843

P5875

Q34398411-829DB36A-63A3-4796-A8F9-2B35C27433C9

P698

Q34398411-FDE194E6-7068-43DE-9393-1FFF76F81E38

P921

Q34398411-9C0A2136-F565-4D5B-B1F2-E6C64559F22D

P932

Q34398411-534DE6B7-410E-4055-9AD4-4246301B3ADF

P356

BLOOD-2014-04-571570

P1433

P1476

T-cell-replete haploidentical ...... ibling HSCT and unrelated HSCT

@en

P2093

Haowen Xiao

http://www.w3.org/2001/XMLSchema#string

Jimin Shi

http://www.w3.org/2001/XMLSchema#string

Jingsong He

http://www.w3.org/2001/XMLSchema#string

Maofang Lin

http://www.w3.org/2001/XMLSchema#string

Wanzhuo Xie

http://www.w3.org/2001/XMLSchema#string

Weiyan Zheng

http://www.w3.org/2001/XMLSchema#string

Xiaohong Yu

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Lai

http://www.w3.org/2001/XMLSchema#string

Xiujin Ye

http://www.w3.org/2001/XMLSchema#string

Yamin Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies

Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States.

P304

2735-2743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-04-571570

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265606933

http://www.w3.org/2001/XMLSchema#string

P698

25214441

http://www.w3.org/2001/XMLSchema#string

P921

P932

4208287

http://www.w3.org/2001/XMLSchema#string